Tarrytown, NY. – May 31st, 2011- ENT and Allergy Associates (ENTA), with seven of its 37 offices-as well as two Practice headquarter locations-situated in Westchester County, today announced that it had significantly further upgraded and expanded its commitment to Westchester County, NY by signing a new lease with Westchester Avenue Associates, a partnership between Simone Development and Fareri Associates.
As of summer of 2011, ENTA’s existing Purchase, NY office will be relocating to a full 4,900 state-of-the-art square feet at 3020 Westchester Ave, from its current location at 3000 Westchester Ave. This cutting edge office, with a staff of 14 employees, is the latest evidence of ENTA’s continued commitment to growth in Westchester County.
“We’re very pleased to have been able to participate with, and accommodate the fantastic growth of ENT & Allergy Associates at our Harrison Executive Park medical campus.” said Joseph Simone, President of Simone Development Companies, the owner and manager of the Harrison Executive Park. “This is consistent with our vision for actively expanding this medical campus and making it the premier location for medical practices in the Westchester area. ENT has been a wonderful tenant of ours for many years here and at our medical office park in the Bronx where they have also expanded their space. It has been remarkable to see their rapid growth at both of our medical parks.”
Simone Development has been an owner and developer of real estate for more than forty years.
The brand new, state-of-the-art Purchase suite offers 8 full ENT exam rooms equipped with leading edge technology, 3 Allergy rooms and 3 audiology rooms. The office, easily accessible from I-287 and just minutes from downtown White Plains, is expected to open summer 2011. This office also serves the patient population of Greenwich and Fairfield County, Ct.
“We’re delighted to get this important lease finalized, and eager to relocate to these incredible new facilities”, commented Jeffrey Jablon, MD, physician partner at ENTA “This move will provide the patient population here in Westchester County with even better medical services, and further enhance our ability to serve them”.
All of ENTA’s current physician roster in Purchase will continue to serve their patients in the new location. Besides Dr. Jeffrey Jablon-board certified Otolaryngologist, this includes Dr. David Lawrence-board certified Otolaryngologist, Dr. Irene Yu-board certified Otolaryngologist and Dr. Ricardo Arayata-board certified in Allergy and Immunology.
“We are extremely proud to tangibly expand our commitment to the health and welfare of the people of Westchester County”, said Wayne Eisman, M.D., President of ENTA, “and are presently recruiting a board certified, fellowship trained laryngologist for this location and the Bronx to further bolster the range of services we provide”.
In addition to ENTA building out this new Purchase space, the Practice has also just expanded its footprint at one of its corporate headquarters, located at 560 White Plains Road in Tarrytown, NY, by leasing additional space on the sixth floor of that building. With over 125 physicians and 58 licensed Audiologists, ENTA is the largest Otolaryngology, Allergy and Audiology practice in the country. The Practice also employs over 550 managerial, clinical, clerical, administrative and ancillary staff, of which 138 employees are sited at both corporate offices, supporting the operations of 37 clinical offices.
Each of the ENT and Allergy Associates, LLP locations provides a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, and Hearing Aid dispensing. Visit www.entandallergy.com for more information. The Practice has a clinical alliance with the Mount Sinai Medical Center for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.